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Proteus mirabilis often complicates the care of catheterized patients through the
formation of crystalline biofilms which block urine flow. Bacteriophage therapy has been
highlighted as a promising approach to control this problem, but relatively few phages
infecting P. mirabilis have been characterized. Here we characterize five phages capable
of infecting P. mirabilis, including those shown to reduce biofilm formation, and provide
insights regarding the wider ecological and evolutionary relationships of these phages.
Transmission electron microscopy (TEM) imaging of phages vB_PmiP_RS1pmA,
vB_PmiP_RS1pmB, vB_PmiP_RS3pmA, and vB_PmiP_RS8pmA showed that all share
morphologies characteristic of the Podoviridae family. The genome sequences of
vB_PmiP_RS1pmA, vB_PmiP_RS1pmB, and vB_PmiP_RS3pmA showed these are
species of the same phage differing only by point mutations, and are closely related
to vB_PmiP_RS8pmA. Podophages characterized in this study were also found to
share similarity in genome architecture and composition to other previously described
P. mirabilis podophages (PM16 and PM75). In contrast, vB_PimP_RS51pmB showed
morphology characteristic of the Myoviridae family, with no notable similarity to other
phage genomes examined. Ecogenomic profiling of all phages revealed no association
with human urinary tract viromes, but sequences similar to vB_PimP_RS51pmB
were found within human gut, and human oral microbiomes. Investigation of
wider host-phage evolutionary relationships through tetranucleotide profiling of phage
genomes and bacterial chromosomes, indicated vB_PimP_RS51pmB has a relatively
recent association with Morganella morganii and other non-Proteus members of the
Morganellaceae family. Subsequent host range assays confirmed vB_PimP_RS51pmB
can infect M. morganii.
Keywords: phage therapy, ecogenomics, biofilms, catheters, bacteriophage
Frontiers in Microbiology | www.frontiersin.org 1 August 2019 | Volume 10 | Article 1783
fmicb-10-01783 August 3, 2019 Time: 15:56 # 2
Alves et al. Genomic and Ecogenomic Characterization of P. mirabilis Bacteriophages
INTRODUCTION
The opportunistic pathogen Proteus mirabilis is a common cause
of catheter-associated urinary tract infections (CAUTIs) and
can significantly complicate the care of patients undergoing
long-term urethral catheterization (Mobley, 1996; Stickler, 2008,
2014). P. mirabilis infection often leads to encrustation and
blockage of catheters in these individuals, which if unnoticed,
can result in the reflux of infected urine to the upper urinary
tract and serious clinical symptoms including pyelonephritis,
septicaemia, and shock (Mobley, 1996; Jacobsen et al., 2008;
Stickler, 2008, 2014). Although blockage is usually not a problem
in hospitalized patients, the majority of long-term catheterized
individuals are cared for in the community where continual
clinical surveillance is not possible, and blockage is often
not detected until subsequent symptomatic complications arise
(Stickler, 2014). As a result, catheter blockage is the underlying
cause of a large proportion of emergency hospital referrals
for individuals undergoing long-term catheterization (Kohler-
Ockmore and Feneley, 1996; Stickler, 2014).
The blockage of catheters by P. mirabilis is derived from the
ability of this organism to form dense biofilms on the surface
of catheters, in conjunction with the production of a potent
urease enzyme (Griffith et al., 1976; Jones and Mobley, 1987;
Stickler et al., 1993; Jones et al., 2005). This highly active enzyme
hydrolyses urea present in the urine and generates ammonia,
which in turn elevates urinary pH (Hedelin et al., 1984; Cox and
Hukins, 1989; Stickler et al., 1993; Holling et al., 2014a,b). Under
these alkaline conditions, calcium and magnesium phosphates
precipitate to form microcrystalline aggregates suspended in
the urine (Stickler et al., 1993; Stickler, 2008). As the biofilm
continues to develop, these crystals become trapped in the
growing community, where the exopolymeric matrix further
stabilizes and enhances their growth, eventually leading to the
development of a mineralized crystalline biofilm structure that
can block urine flow (Stickler et al., 1993; Stickler, 2008).
Although catheters designed to prevent CAUTIs and impede
biofilm formation have been developed, they remain prone to
encrustation and blockage by P. mirabilis, and are considered
ineffective in long-term settings (Morris et al., 1997; Morgan
et al., 2009; Stickler, 2014). This includes catheters approved
for use within the United Kingdom National Health Service;
for example, antimicrobial catheters coated with silver or
nitrofurazone have been shown to have no significant impact on
the incidence of CAUTI, even during short-term catheterization
(Pickard et al., 2012). P. mirabilis also frequently causes
chronic infection in long-term catheterized patients and
can persist after catheter changes and multiple rounds of
standard antibiotic treatment (Kunin, 1997). Therefore, there
are currently no fully effective approaches to prevent or
manage catheter blockage due to P. mirabilis CAUTI, and new
strategies are required to deal with this persistent and growing
clinical problem.
Previously, we have explored the use of bacteriophage
(or phage) to combat P. mirabilis crystalline biofilm formation,
and demonstrated the potential for this approach to control
catheter encrustation (Nzakizwanayo et al., 2016). A combination
of three phages that infect P. mirabilis were applied to in vitro
models of the catheterized urinary tract. This cocktail was
able to significantly inhibit crystalline biofilm formation in
experiments simulating an established infection and completely
eradicated P. mirabilis from models in experiments simulating
the early stages of infection (Nzakizwanayo et al., 2016). Other
P. mirabilis phages have also been characterized with therapeutic
applications in mind, and include the podophages PM16, PM75
and vB_PmiP_5460 (Melo et al., 2016; Morozova et al., 2016,
2018), the Siphophage pPM_01 (Wirjon et al., 2016), and the
Myophage vB_PmiP_5461 (Melo et al., 2016). Notably, phages
vB_PmiP_5460 and vB_PmiP_5461 have also been demonstrated
to reduce crystalline biofilm formation in models of CAUTI
(Melo et al., 2016).
However, there is presently a general paucity of data regarding
phages that infect P. mirabilis, and in order to fully explore
the potential for phage therapy to control this pathogen, as
well as to optimize the development of effective phage cocktails,
a greater understanding of phages infecting this species is
required. Here we describe the full genomic sequence and
characterization of phages infecting P. mirabilis, including
those previously shown to have potential utility in controlling
crystalline biofilm formation (Nzakizwanayo et al., 2016). We
demonstrate how genomic and ecogenomic profiling of these
phages can identify broader affiliations with various microbial
ecosystems and other bacterial host species. Collectively, these
genomic and ecogenomic approaches will aid the development
of phage cocktails for the control of P. mirabilis and other urinary
tract pathogens.
MATERIALS AND METHODS
Bacterial Strains, Media, and
Routine Culture
Clinical isolates of P. mirabilis used in this study were
obtained from the Royal Sussex County Hospital (Brighton,
United Kingdom), and all were isolated from urinary tract
infection sites (Supplementary Table S1). All chemicals, reagents
and growth media were obtained from either Thermo Fisher
Scientific, United Kingdom, Oxoid, United Kingdom, or Sigma,
United Kingdom, unless otherwise stated. Bacteria were routinely
cultured in Luria-Bertani (LB) medium (5 g/L yeast extract,
10 g/L tryptone, 10 g/L sodium chloride) at 37◦C with shaking,
or on LB solidified by addition of 15 g/L Technical agar (LA).
Soft agar overlays, used for phage enrichments, purification and
enumeration, were derived from LB, and contained 6.5 g/L
Technical agar (S-LA).
Phage Isolation and Purification
Phages were isolated from wastewater collected from treatment
plants in the United Kingdom (Anglian Water, Milton Keynes,
Luton, and Sharnbrook). Enrichments for phages active against
P. mirabilis were performed by mixing 100 mL of wastewater with
387.5 mL of LB, and subsequent inoculation with 2.5 mL of an
overnight culture of P. mirabilis (see Supplementary Table S1
for host strains). This was incubated at 37◦C overnight without
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shaking. 10 mL aliquots were centrifuged (3000×g for 30 min),
and supernatants filtered into fresh sterile tubes using 0.45 µm
pore syringe filters (Sartorius, United Kingdom). 3 mL S-LA
inoculated with 100 µL of an overnight P. mirabilis culture
was mixed with 100 µL of filtered enrichment, swirled gently,
and immediately poured over the surface of a LA plate. Plates
were incubated at 37◦C for 18–20 h, and phage with the
ability to infect the host strain were identified by observing
zones of lysis (plaques) in the agar. To isolate distinct phage,
individual plaques were picked off using Pasteur pipettes and re-
suspended in 300 µL suspension medium (SM) buffer (100 mM
NaCl, 10 mM MgSO4.7H2O, and 50 mM Tris–HCL pH 7.5,
0.01% gelatine). The resulting phage suspensions were serially
diluted in SM Buffer, and the dilutions used to prepare agar
overlays with overnight cultures of P. mirabilis, and plates
incubated at 37◦C overnight. To ensure phage purity, this process
was repeated a further 5 times until bacterial lawns showed
homogeneity of plaque morphology. An individual plaque was
then picked off and re-suspended in SM buffer for use in
subsequent experiments. Purified phage suspensions were stored
at 4◦C until required.
Preparation of High Titre Phage Stocks
To prepare high titre stocks of isolated phage (1010 pfu/ml),
phages were propagated on their original host strain in LB
broth (Supplementary Table S1), and 100 µL of the resulting
phage lysate mixed with 100 µL of a fresh overnight culture of
P. mirabilis. This was incubated for 5 min at room temperature
without shaking, before being used to prepare soft agar overlays
on LB agar plates, as described above. After an overnight
incubation at 37◦C, plates displaying confluent lysis were selected
and flooded with 3 mL of SM buffer supplemented with 2% (v/v)
chloroform, before incubation at 37◦C for 4 h. The resulting
phage suspension was removed from the plates, centrifuged
(11,000 × g for 10 min) to remove cell debris, and filtered using
0.22 µm pore size syringe filters. In order to further concentrate
the phage, one volume of 20% PEG-8000 solution supplemented
with 1M NaCl (Sigma, United Kingdom) was added to the phage
suspension and incubated at 4◦C overnight, before centrifugation
at 11,000× g for 20 min. The resulting pellet was re-suspended in
SM buffer and a 1/5 volume of chloroform was added, vortexed
for 30 s to mix, followed by slow centrifugation (3,000 × g for
15 min at 4◦C). The upper aqueous phase was removed and
stored at 4◦C until required.
Infection of Non-Proteus Species
The ability of phage to infect and replicate in alternate host
species, was evaluated using spot tests of phage suspensions
on agar overlays seeded with potential host bacteria. Isolates
of species tested were obtained from DSMZ, and are described
in Supplementary Table S1. For each bacterial species tested,
100 µL of an overnight culture was mixed with 3 mL of S-LA
and poured onto a LA plate. Plates were left to dry for 20 min at
37◦C. Phage lysates were standardized to a titre of 109 PFU/mL,
and 10 µL of each lysate was spotted onto the bacterial lawns
at concentrations ranging from 103 to 109 PFU/mL, and plates
incubated overnight at 37◦C. This assay was performed in
triplicate, and evidence of phage replication taken as formation
of plaques in the region of the spotted phage suspension.
Electron Microscopy
Purified phage particles at a concentration of 109 PFU/mL
were deposited on 300 mesh carbon-coated copper grids (Agar
Scientific, United Kingdom) and negatively stained with 1%
uranyl acetate (pH 4) as follows: the surface of the copper grids
were ionized for 2 min immediately prior to sample deposition.
5 µL of phage lysate were spotted on the surface of the grid and
allowed to stand for 1 min. This was followed by 30 sec negative
staining and subsequent air drying of the grid. Visualization was
performed using a JEOL JEM-1400Plus TEM, operated at 120 kV
(pixel size = 0.1 nm), equipped with a Gatan OneView 4K camera
with automatic drift correction.
Phage DNA Sequencing, Assembly, and
Inference of Physical Genome Structure
Phage genomic DNA was extracted through a direct plaque
sequencing method described by Kot et al. (2014). DNA
sequencing libraries were prepared using the Nextera XT DNA
kit (Illumina, San Diego, CA, United States), according to
the manufacturer’s protocol. Individually tagged libraries were
sequenced as part of a flow cell as 2 × 250 base paired-end reads
using the Illumina MiSeq platform (Illumina, San Diego, CA,
United States). Reads were analyzed, trimmed, and assembled
using CLC Genomic Workbench version 6.5.1, as described
previously (Kot et al., 2014).
Nanopore sequencing was conducted using multiplex bar-
coded sequencing of phage genomic libraries on the Oxford
Nanopore Technologies (ONT) MinION sequencing platform.
Genomic DNA was extracted from high titre phage stocks
(1010 pfu/mL) using the Zinc precipitation method originally
described by Santos (1991), with some minor modifications
previously outlined in Ogilvie et al. (2012). The quantity and
purity of the resulting DNA was tested using the Qubit 2.0 and the
Nanodrop 2000, respectively. Sequencing libraries were prepared
according to the ONT protocols for the Native Barcoding Kit
(EXP-NBD103), and the Ligation sequencing Kit 1D (SQK-
LSK108). For each phage, 1 µg of total genomic DNA was
treated with the NEBNext End repair/dA-tailing Module (E7546;
New England Biolabs), purified using 1× volume AMPure XP
beads (Beckman Coulter), then eluted in nuclease – free water
(25 µL). Next, 500 ng of each end – repaired adenylated
DNA was ligated to one of the Native Barcodes (selected from
NB01 to NB12; ONT) using the Blunt/TA Master Mix (M0367;
New England Biolabs), cleaned using the AMPure XP beads,
then eluted in nuclease – free water (26 µL). The barcoded
samples were combined in equimolar amounts to produce a
pooled sample of 700 ng in 50 µL nuclease-free water and
Barcode Adapter ligation performed using T4 DNA ligase in
the NEBNext Quick Ligation Module (E6056; New England
Biolabs). The resulting library was eluted in the Nanopore
Elution Buffer (15 µL) and amount of DNA quantified using
the Qubit 2.0 to confirm total DNA recovery of ∼500 ng. The
final library (12 µL) was mixed with Nanopore Running Buffer
Frontiers in Microbiology | www.frontiersin.org 3 August 2019 | Volume 10 | Article 1783
fmicb-10-01783 August 3, 2019 Time: 15:56 # 4
Alves et al. Genomic and Ecogenomic Characterization of P. mirabilis Bacteriophages
with Fuel Mix (35 µL), Library Leading Beads (25.5 µL), and
Nuclease-fee water (2.5 µL). This mixture was loaded onto a pre-
primed single R9.4/FLO-MIN106 flow cell in a MinION Mk1B,
and run for 48 h.
The resulting MinION reads were subject to basecalling
using Albacore v2.3.1, and reads demultiplexed and trimmed
using Porechop (v0.2.4 October 20181). Nanopore reads with a
minimum length of 500 nucleotides were subsequently assembled
using CANU 1.17 (Koren et al., 2017) using default settings
for assembly of raw nanopore reads, and assuming a maximum
possible genome size of 50 or 100 kb. MinION assemblies
were used to infer the physical structure and terminal repeat
sequences of phage genomes through Mauve alignments v2.3.1
(Darling et al., 2004; implemented in Geneious 9.1.8), with initial
Illumina assemblies. Terminal repeats in podophage genomes
were detected using the Geneious 9.1.8 repeat finder tool as well
as through comparison to the previously described podophage
PM16 and PM75 (Morozova et al., 2016, 2018). Subsequently,
Illumina assemblies were corrected manually to reflect the
predicted physical genome structure of phage, and verified
by comparison of predicted vs. actual restriction profiles of
the phage genomes.
Restriction Digest of Phage Genomes
For restriction digest of phage genomes, phages were propagated
on host strains and purified and harvested by filtration (0.22 µm
pore size), followed by concentration using VIVASPIN
R©
15
10,000MWCO PES membranes (Sartorius). Concentrated phage
lysate (1 mL) was treated with 10 µg DNAse I (Sigma-Aldrich)
and 5 µg RNase A (Sigma-Aldrich) for 30 min at 37◦C, prior to
extraction of phage DNA using the QIAmp Min Elute Virus Spin
kit (QIAGEN). Recovered phage DNA was digested using EcoRI
and XbaI individually, according to manufacturer’s instructions
(Fermentas Fast Digest
R©
enzymes), and restriction fragments
separated using agarose gel electrophoresis.
Annotation and Analysis of Phage
Genomes
Open reading frames (ORFs) were predicted from Illumina
assemblies using Glimmer V3 (implemented in Geneious 9.1.8).
The putative functions of the ORFs were predicted using
translated ORF amino acid sequences in BlastP searches of the full
non-redundant protein sequence database and NCBI CD-Search
queries of the Conserved Domain Database (encompassing
models from COG, Pfam, SMART, PRK, and TIGRFAM
databases). Only BlastP hits with a minimum 20% identity and
e-values of 1e−5, and Conserved Domain hits with e-values
on 1e−2 were used to assigned putative functions to ORFs.
Phage encoded ORFs were also used to search the Virulence
Factor Database (October 2017) (Chen et al., 2005, 2016), and
the MEGARes antibiotic resistance gene database (December
2016) (Lakin et al., 2017). In both cases, only hits generating a
minimum of 20% identity and e-values of 1e−5 or lower were
considered valid.
1https://github.com/rrwick/Porechop
Analysis of Proteins in Mature Phage
Particles
The phage proteins were identified as previously described in
Carstens et al. (2016). Briefly, 75µL of the purified phage solution
was mixed with 75 µL of 1% SDS and incubated for 30 min at
80◦C followed by Trichloroacetic acid (TCA) precipitation. The
proteins were re-solubilized in 8 M urea, 45 mM dithiothreitol
(DTT), and 50 mM Tris, pH 8.0, reduced and alkylated. The
proteins were trypsin digested and the resulting peptides analyzed
using a Dionex 3000 rapid separation liquid chromotography
(RSLC) ultra high performance LC (UHPLC) system (Thermo
Fisher Scientific, Hvidovre, Denmark) with an Aeris PEPTIDE
1.7 µm XB-C18, 150 mm × 2.1 mm column (Phenomenex,
Værløse, Denmark) coupled to a Q Exactive mass spectrometer
(Thermo Fisher Scientific, Hvidovre, Denmark). The resulting
data were analyzed with Proteome Discoverer software (version
1.4, Thermo Fisher Scientific, Hvidovre, Denmark), using an in
house protein database based on the obtained DNA sequences.
The search results were filtered using the integrated Target decoy
peptide–spectrum matches (PSM) validator algorithm set to a
q-value of <0.01, which ensures a peptide-spectrum match false
discovery rate less than 0.01.
Analysis of Tetranucleotide Usage
Profiles in Phage Genomes
Tetranucleotide usage profiles from phage genomes and bacterial
chromosomes were calculated using the method of Teeling et al.
(2004), adapted by Ogilvie et al. (2012, 2013). Sequences were
extended by their reverse complement before usage profiles for
all possible 256 tetranucleotide combinations were calculated
over a 1 nt sliding window. The resulting counts for each
tetranucleotide were converted to Z-scores and used for further
analyses with the R packages Vegan and BioDist. For analysis
of similarity (ANOSIM), Z-scores were utilized without further
processing, whereas for non-metric multidimensional scaling
(nMDS) Z-scores from each sequence were first used to construct
Euclidian distance matrices using Vegan. The resulting matices
were then used for nMDS ordination with 1000 random
starts. Cladograms were constructed from Pearson dissimilarity
matrices of Z-scores (generated using the BioDist package), using
the neighbor-joining algorithm in Vegan (with 500 bootstrap
replicates). The resulting cladograms were further analyzed
to derive the majority consensus tree, and annotated using
Dendroscope v3.5.7.
Representation of Phage-Encoded
Sequences in Metagenomic Datasets
Ecogenomic analysis of sequences with similarity to ORFs
encoded by P. mirabilis phage in metagenomic datasets was
performed as previously described (Ogilvie et al., 2012, 2013).
Datasets searched represent a range of different habitats within or
on the human body, as well as range of habitats from marine and
terrestrial environments. The details of metagenomic datasets
searched can be found in Supplementary Table S2. Datasets
were searched using tBlastn with amino acid sequences from
each predicted phage ORF, and valid hits were considered to
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be those generating ≥35% identity over ≥50% of the query
sequence and an e-value of ≤1e−5. Valid hits were subsequently
used to calculate the relative abundance of each phage-encoded
ORF in each dataset (expressed as Hits/Mb of sequence data).
The cumulative relative abundance of ORFs encoded by each
phage was taken as the sum of all individual ORF relative
abundances. Blast searches and calculation of relative abundance
were automated using a custom PERL script as described
in Ogilvie et al. (2018) (access and support is available on
request to authors), which implemented BLAST v2.2.29 with
default settings.
Statistical Analysis
All statistical analyses were performed using Prism 6.0c for Mac
OS X (GraphPad Software, Inc., United States), or the R packages
Vegan and BioDist (for nMDS, ANOSIM, and Cladograms).
Significant differences in cumulative relative abundances between
metagenomes were assessed using the Kruskal-Wallis test with
Dunn’s correction for multiple comparisons.
Phage Names and Accession Numbers
All phage sequences were named according to guidelines from
the International Committee on Viral Taxonomy (Adriaenssens
and Brister, 2017), and have been deposited in GenBank
under the following accession numbers: Proteus_phage_
vB_PmiP_RS1pmA (also representing RS1pmB and RS3pmA) –
MG575418; Proteus_phage_vB_PmiP_RS8pmA – MG575419;
Proteus_phage_vB_PmiM_RS51pmB – MG575421.
RESULTS
Phenotypic Characterization of
P. mirabilis Phage
Phages capable of infecting P. mirabilis (designated Proteus_
phage_vB_PmiP_RS8pmA, and Proteus_phage_vB_PmiM_
RS51pmB) were isolated from sewage using clinical isolates of
P. mirabilis recovered from urinary tract infections. Phages
were initially characterized based on plaque and virion
morphology and compared to previously isolated phages
(Proteus_phage_vB_PmiP_RS1pmA, RS1pmB, and RS3pmA),
which have been shown to reduce P. mirabilis crystalline biofilm
formation when tested in vitro infection models (Nzakizwanayo
et al., 2016). For simplicity, we refer to phage by their unique
identifiers for the remainder of the manuscript: RS1pmA,
RS1pmB, RS3pmA, RS8pmA, and RS51pmB.
Analysis of virion structure by TEM (Figure 1) showed
that RS8pmA is likely a member of the Podoviridae family
based on the short length of tails (∼10 nm in length), and
similar to the previously isolated podophage RS1pmA, RS1pmB,
and RS3pmA (Nzakizwanayo et al., 2016). RS8pmA was also
observed to generate plaques with similar morphology to the
previously isolated phages, including surrounding halos that
are considered indicative of polysaccharide depolymerase (PD)
activity (Figure 1; Sutherland et al., 2004). In contrast, TEM
showed RS51pmB virion morphology aligned with membership
FIGURE 1 | Capsid and plaque morphology of Proteus mirabilis phages.
Images show transmission electron microscopy (TEM) projections of
negatively stained phage (left), and examples of plaques formed by each
phage on lawns of host bacteria (right). Phage capsid structures were
congruent with membership of the Podoviridae family (RS1pmA and
RS8pmB), and the Myoviridae family (RS51pmB). RS1pmA is used to
represent the previously described group of phages RS1pmA, RS1pmB and
RS3pmA, which all have analogous capsid morphology (Nzakizwanayo et al.,
2016). Scale bars show 50 nm on TEM images and 1 cm on images of
plaques. TEM images shown are representative of at least 10 fields of view
containing one or more virions.
of the Myoviridae family (Figure 1). RS51pmB generated small
circular plaques of a consistent diameter, with no evidence of PD
activity (Figure 1). All phages generated clear plaques with no
indication of lysogenic replicaiton apparent.
Analysis of P. mirabilis Phage Genomes
and Inference of Physical Structure
Phage genomes were initially generated using Illumina
sequencing to an average depth of ∼181× coverage. However,
the repeat sequences that are often present at the terminal ends
of podophage genomes, and other terminally redundant features
of phage genomes (arising from particular replication strategies),
can lead to mis-assembly of short read data. To account for
this we also generated phage genome assemblies from long-read
nanopore sequencing methods, which were used in combination
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FIGURE 2 | Functional content and characteristics of P. mirabilis phage genomes. Maps show the physical gene architecture of P. mirabilis phages RS1pmA,
RS51pmB, and RS8pmA. Block arrows represent positions of open reading frames (ORFs) with colors indicating affiliation to broad functional groups relevant to
phage replication, as denoted by the associated key: Cell Lysis, predicted to encode for activities involved in lysis of host cells; Replication and Regulation, predicted
to encode for activities involved in replication of phage genomes and regulation of this process; Structure and Packaging, predicted to encode components of the
phage capsid or support packaging of new phage genomes during replication; Unknown Phage related, unknown function but homologous sequences identified in
other phage genomes; Unknown, generated no valid hits in BlastP or Conserved Domain searches. Putative functions of each ORF were predicted using BlastP and
conserved domains (CD) searches against the nr database (BlastP: minimum 20% identity, 1e-5 or lower; CD: 1e-2 or lower).
with restriction digests to infer the correct physical structure of
phage genomes, identify terminal repeats, and correct Illumina
assemblies (Figure 2).
This analysis indicated that the initial Illumina assemblies
of phage genomes generated in this study (RS1pmA, RS1pmB,
RS3pmA, RS8pmA, and RS51pmB) did not reflect the correct
physical structure of phage genomes, most likely due to merging
of terminal repeat regions during assembly. Restriction digest
of phage genomes confirmed the nanopore-corrected Illumina
assemblies provided a more accurate representation of the
physical genome structure of these phages (Supplementary
Figures S1, S2). In the case of RS51pmB, MinION data, and
restriction digests also indicated this phage genome to be
circularly permuted with terminal redundancies, indicative of the
headful packaging mechanism observed in other members of the
Myoviridiae (Schwudke et al., 2008; Casjens and Gilcrease, 2009;
Yap and Rossmann, 2014). However, the packaging strategies
used by these phages, the exact sequence and positions of repeats
or regions of terminal redundancy, and the related molecular
details of genome replication will require further detailed studies
to confirm and elucidate.
Genome sequences of RS1pmA, RS1pmB, and RS3pmA
revealed these to be species of the same phage, differing only
by 7 point mutations at several locations in their genome
sequences (Figure 2 and Supplementary Figure S3). Five of
these point mutations were predicted to lead to amino acid
substitutions, and were predominantly associated with genes
predicted to encode structural proteins in mature viral particles,
including those likely to play a direct role in host attachment
such as tail fiber proteins (Supplementary Figure S2). Due
to the high level of identity between RS1pmA, RS1pmB and
RS3pmA, subsequent analyses were conducted using RS1pmA as
a representative of this group of phages. RS8pmA also exhibited
notable similarities in genome sequence and gene synteny to the
RS1 group of phages, in keeping with these phages all exhibiting
similar virion morphology and belonging to the Podoviridiae
family (Figure 2, Supplementary Figure S4, and Supplementary
Data S1). In contrast, RS51pmB was found to encode distinct
genome organization and gene contents from the other phages
analyzed, congruent with differences in the virion morphology of
this phage as compared to RS1pmA and RS8pmA (Figure 2 and
Supplementary Data S1).
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When ORFs in each genome were assigned to broad categories
based on putative function (as described in Figure 2), similar
proportions of genes predicted to be involved in virion structure,
aspects of regulation and replication, and host cell lysis, were
observed in most phage genomes (Figure 2). As with many other
phage genomes, a high proportion of ORFs with no identifiable
function were also observed in all phage genomes. Although some
of the ORFs with unknown function were found to also have
homologs in other phage genomes, many showed no similarities
to any sequences currently present in the NCBI non-redundant
database (Figure 2). None of the phage genomes characterized
here encoded identifiable genes for virulence factors or antibiotic
resistance determinants.
Analysis of Mature Virion Proteomes
To support in silico predictions of virion-associated structural
genes, the proteome in mature phage particles was also
analyzed (Figure 2 and Supplementary Table S3). In RS1pmA
and RS8pmA this confirmed predictions of virion-associated
genes based on BlastP and Conserved Domain homologies
(Figure 2 and Supplementary Table S3). However, for RS51pmB,
proteomic analysis failed to detect the predicted products for
most capsid-associated ORFs (Figure 2 and Supplementary
Table S3). There were also indications that proteins related
to genes of unknown function (but with homologs in other
phage genomes; RS51pmB), or ORFs predicted to encode
polynucleotide kinase (RS1pmB and RS8pmA), are potentially
present in mature virions (Figure 2 and Supplementary
Table S3). Alternatively, the detection of proteins assigned
functions in replication and regulation could conceivably result
from protein carry over in phage lysates, and the role, if any,
of these proteins in the mature virion will require further
investigation to confirm.
Representation of P. mirabilis Phage
Genes in Other Phage Genomes
To evaluate similarities between the P. mirabilis phages isolated
here and phage infecting other bacterial host species, we used
all ORFs encoded by each P. mirabilis phage to search a
collection of 715 publicly available phage genomes. This analysis
demonstrated that the podophages RS1pmA and RS8pmA
exhibit high levels of similarity to other available Proteus
phage genomes, with 89–90% of ORFs encoded by these
phages affiliated predominantly with PM16 (NC_027342), and
PM75 (NC_027363) (Morozova et al., 2016, 2018; Figure 3
and Supplementary Data S1). The similarity of RS1pmA and
RS8pmA was explored further through pairwise alignments of
these phage genomes with complete genomes of PM16 and PM75.
This confirmed overall similarity and gene synteny between
these phages (as well as providing further support for validity of
the MinION-corrected genome structures), but also highlighted
distinct variations across the genome sequences (Supplementary
Figure S5). In contrast, RS51pmB did not exhibit any notable
similarity to other Proteus phage genomes, and the majority of
RS51pmB ORFs were not affiliated with any phage genomes
searched using this approach (72.3%). The RS51pmB ORFs that
could be affiliated with other phage genomes were associated
with phage infecting a diverse array of Proteobacterial hosts,
predominantly Gamma-proteobacteria, including Salmonella,
Klebsiella, Escherichia, Vibrio, Aggregatibacter and Actinobacillus
spp. (Figure 3 and Supplementary Data S1).
Evaluation of Broader Evolutionary
Host-Phage Relationships
To gain further insight into the potential broader evolutionary
relationships of the P. mirabilis phages isolated in this study,
we used alignment-free correlations of tetranucleotide usage
patterns to discern potential associations between Proteus phage
genomes characterized within the present study, and bacterial
chromosomes from a range of species. This approach exploits
similarities in global nucleotide usage patterns that develop
between phage genomes and the chromosomes of long-term
bacterial hosts (Pride et al., 2006; Ogilvie et al., 2012, 2013).
The underlying hypothesis is that in phage which have recently
become capable of infecting and replicating in a new host species,
nucleotide usage profiles adapt more slowly and initially still
reflect previous long-term hosts (Ogilvie et al., 2013, 2018).
Initial relationships were explored between the phages
characterized in this study, other available P. mirabilis phages,
and a collection of Gammaproteobacteria genomes representing
genera to which other common urinary tract pathogens belong
(Stickler, 2014). Initially, unsupervised ordination of phage and
bacterial genomes by nMDS coupled with ANOSIM, was used
to visualize potential relationships between Proteus phages and
bacteria from different families (Figures 4A,B). This analysis
indicated no detectable relationship between Proteus phages
and members of the Enterobacteriacea, Pseudomonadaceae,
and Yersiniaceae represented (Figures 4A,B). As expected, the
Morganellaceae group, to which Proteus sp. belong, showed the
closest association with Proteus phages (Figures 4A,B).
To explore these potential relationships in more detail,
phage sequences and bacterial genomes were used to construct
cladograms based on tetranucleotide profiles (Figure 4C).
While this supported the nMDS and ANOSIM analyses and
showed a general association of Proteus phages with bacterial
genomes from species belonging to the Morganellaceae, this also
revealed distinct differences between RS51pmB and other phages.
RS51pmB did not cluster with other Proteus phages and was
less closely associated with P. mirabilis genomes (Figure 4C).
This separation was also observed directly in tetranuclotide usage
profiles of RS1pmA and RS51pmB, when these were correlated
with other Proteus phages and used to construct scatterplots
(Figure 4C inset). To further test this observation, we also
used Blast searches to affiliate each ORF encoded by RS51pmB
with all bacterial genomes belonging to genera clustering with
these phages in cladograms (Proteus, Morganella, Providencia,
and Serratia) (Figure 4D). This also supported an association
of RS51pmB with non-Proteus species, with the majority of
assignable ORFs being affiliated to Morganella and Providencia
sp. (Figure 4D).
Collectively, these analyses indicated the potential for
RS51pmB to have a previous or ongoing evolutionary
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FIGURE 3 | Representation of P. mirabilis phage-encoded ORFs in other phage genomes. The representation of P. mirabilis ORF homologs in other phage genomes
was explored using tBLASTn searches of 715 complete phage genomes. The proportion of ORFs affiliated to other phage genomes is based on top hit by bit score
(min 35% identity, over ≥25 amino acids, 1e-5 or lower). Hits were categorized by genus of host bacterial species for phage genomes generating each hit. Legends
associated with charts describe bacterial genera represented. The “Gamma Proteobacteria” group included Hamiltonia sp., Listonella sp., and Pseudoalteromonas
sp., which were each represented by less than two hits across all phage genomes. RS51pmB also only generated a single hit to phage infecting Mycobacterial sp.
ORFs generating no valid hits in tBlastn searches are designated as “Unknown.” ∗RS1pmA is used to represent the previously described group of phages RS1pmA,
RS1pmB, and RS3pmA (Nzakizwanayo et al., 2016), which were found to differ only by point mutations (see Supplementary Figure S3).
relationship with non-Proteus host species from these bacterial
Genera. To explore this further, we tested the potential for
RS1pmA, RS8pmA, and RS51pmB to replicate in potential
alternate hosts represented in relevant clusters of the cladogram.
Although it was not possible to use an exhaustive panel of species
and strains, these experiments did demonstrate RS51pmB to
be capable of infecting Morganella morganii (albeit inefficiently
compared to P. mirabilis), supporting the inference of a
relationship with non-Proteus hosts based on tetranucleotide
usage profiles (Figure 4E). However, it should be noted that
more extensive host-range assays will be required to determine
how robust these relationships are, and fully understand the host
range of these phages.
Ecogenomic Profiling of P. mirabilis
Phage
To gain further insight into the broader ecological associations
of these P. mirabilis phages, we also investigated the relative
representation of sequences similar to P. mirabilis phage
encoded ORFs in other bacterial ecosystems (Figure 5). No
phage analyzed exhibited notable representation in metagenomes
derived from human urinary tract viromes or environmental
datasets, but associations with other human-derived habitats
were observed (Figure 5A). As with the other analyses conducted
here, RS1pmA and RS8pmA exhibited similar profiles, which
were markedly different to those obtained for RS51pmB
(Figures 5A,B). ORFs with similarity to those encoded by
RS1pmA and RS8pmA were only poorly represented in the
metagenomic datasets examined, with no statistically significant
representation in any habitat, but with most homologs identified
in datasets from the human oral cavity (Figure 5B).
In comparison, sequences similar to RS51pmB encoded ORFs
showed significantly greater representation in metagenomic
datasets than RS1pmA and RS8pmA, and a particular association
with human-associated microbial or viral communities from
the oral cavity, gastrointestinal tract and other body sites
(Figure 5). In the case of RS51pmB, a wider range of ORFs
was found to be generally well represented in the metagenomic
datasets examined, with greatest representation in human oral
microbiomes (ORFs 44 and 51), human gut microbiomes and
viromes (ORFs 18, 44, 51, and 70), and human body associated
datasets (ORF 51). These ORFs were predicted to encode a
large terminase subunit (ORF 51); methyltransferases (ORFs 18
and 70) and a structural protein (ORF 44) (Figure 5B and
Supplementary Data S1).
DISCUSSION
The potential for phages to control CAUTI, and in particular
biofilm formation on urinary catheters, has previously been
demonstrated using various models of infection (Curtin and
Donlan, 2006; Carson et al., 2010; Fu et al., 2010; Lehman
and Donlan, 2015; Melo et al., 2016; Nzakizwanayo et al.,
2016). Phages offer a number of advantages over conventional
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FIGURE 4 | Evaluation of broader evolutionary relationships and host affiliations. The potential for broader evolutionary relationships between P. mirabilis phages and
other bacterial hosts were explored by comparing P. mirabilis phages with bacterial genomes belonging to genera containing the most common Gram-negative
pathogens of the catheterized urinary tract (Proteus, Providencia, Morganella, Pseudomonas, Escherichia, Klebsiella, Enterobacteria, and Serratia) (Stickler, 2014).
(A) Unsupervised ordination using nMDS was initially used to visualize relationships between all sequences based on tetranucleotide usage profiles (Ogilvie et al.,
2012, 2013). Bacterial genomes were classified by family. For nMDS, points show position of individual genomes in the final ordination, with connecting lines
indicating relationship to the group centroid. Filled ellipses show standard deviation of group dispersion relative to the group centroid. Ordination were based on an
Euclidean distance matrix of tetranucleotide usage profiles from each sequence. nMDS analysis was conducted with 1000 random starts using the R package
Vegan. (B) ANOSIM between groups of sequences represented in the nMDS ordination. Charts show the ANOSIM R Statistic for each group of bacterial genomes
vs. the P. mirabilis phage group, where an increasing strength of separation between groups is indicated as the R Statistic approaches 1. ∗∗Denotes statistical
significance of R Statistics between groups, P ≤ 0.001 (calculated as part of the ANOSIM in the R Package Vegan). (C) Cladogram based on tetranucleotide usage
profiles showing relationship between P. mirabilis phage sequences and genomes from Morganellaceae and Yersiniaceae groups represented in nMDS ordinations.
The cladograms were constructed from a Pearson dissimilarity matrix of tetranucleotide profiles from all sequences used in nMDS analyses as majority consensus
trees from 500 bootstrap replicates (as calculated by the R package BioDist). The cladogram presented shows a sub-region of the larger tree populated by
P. mirabilis phages and the most closely related bacterial genomes by this analysis. Chart Inset: shows differences between P. mirabilis phage sequences, based on
scatter plots of phage RS1pmA and RS51pmB tetranucleotide correlation scores with other phage sequences. (D) To further test relationships in phage RS51pmB
indicated by tetranucleotide analyses, ORFs from this phage were searched against all sequences from genus level taxonomic groups represented in cladograms
(Proteus, Providencia, Morganella, and Serratia) using BlastP, and hits used to assign a taxonomic affiliation. Only hits with a maximum e-value of 1e-3 were
considered valid. Charts show the proportion of assignable ORFs affiliated to each genus, and the proportion of assigned and unassigned ORFs. (E) To test if the
relationships with non-Proteus species indicated in tetranucleotide and Blast analyses were relevant to the host range of this phage, the ability of RS51pmB to
replicate in species other than P. mirabilis was tested (Supplementary Table S1). The image presented demonstrates the ability of phage RS51pmB to use
M. morganii as an alternate host species (Supplementary Table S1). Host range assays were performed in triplicate at phage titres ranging from ∼10 to 107 PFU,
with the image shown representative of M. morganii lawns exposed to 107 PFU of RS51pmB.
antimicrobials for the control of biofilm-associated infections,
including mechanisms evolved to penetrate biofilms and access
bacterial hosts normally protected by the matrix of extracellular
polymeric substances (Sutherland et al., 2004; Lu and Collins,
2007). Phages are also not generally affected by a host species
susceptibility to conventional antimicrobial agents, and may
therefore also contribute to efforts to control antimicrobial
resistance and address this global challenge.
This makes phages potentially well suited for controlling
infections where biofilm formation is an important feature,
and situations in which conventional antimicrobial agents often
perform poorly (Sutherland et al., 2004; Lu and Collins, 2007;
Stickler, 2014; Melo et al., 2016; Nzakizwanayo et al., 2016).
There is also the potential to use phage in synergy with
conventional antibiotic treatments, which may have considerable
benefits in terms of enhanceing treatment efficacy, as well as
curtailing the emergence of antibiotic resistant strains. It is also
worth noting that phages isolated in this and our previous study
were all recovered from sewage samples, using clinical isolates
of P. mirabilis as the host species (Nzakizwanayo et al., 2016).
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FIGURE 5 | Ecogenomic profiling of P. mirabilis phage encoded functions. The representation of functions encoded by P. mirabilis phages in a range of microbial
habitats was investigated by calculating the relative abundance of similar sequences in 809 metagenomic data sets. Valid hits from tBlastn searches with P. mirabilis
phage sequences (≥35% identity, ≥50% query coverage, ≤1e-5) were used to calculate the average relative abundance of ORF homologs in each dataset
(expressed as Hits/Mb). (A) The heatmap shows average relative abundance of ORFs from each phage in metagenomes or viromes from various habitats. Rows
represent datasets grouped by habitat, and columns represent individual phage. The intensity of shading in cells indicate cumulative relative abundance of ORFs
from a given phage in metagenomes from the corresponding habitat (according to the scale shown). The associated histogram shows average relative abundance of
phage ORFs across all datasets. (B) Heatmaps show cumulative relative abundance of individual ORFs from each phage (Rows) in metagenomes from various
habitats (Columns), and shading of cells indicates relative abundance according to the associated scale. Associated histograms show the proportion of ORFs in
each phage with homologs detected in various habitats represented by metagenomes surveyed. ∗∗∗∗P < 0.0001 (Kruskal-Wallis test with Dunn’s correction), error
bars show standard error of the mean. RS1pmA is used to represent the previously described group of phage RS1pmA, RS1pmB, and RS3pmA (Nzakizwanayo
et al., 2016). ENV, whole community metagenomes with non-host associated environmental origin (n = 16); HGUT, HORAL, and HBODY, whole community
metagenomes from the human gut microbiome, the human oral cavity, or various human body sites (primarily external) (n = 285, 295, and 181, respectively). HGV,
viral metagenomes from the human gut (n = 12). UTV, viral metagenomes from the human urinary tract (n = 20). Details of datasets used can be found in
Supplementary Table S2.
This further highlights that phages with potential therapeutic
value can be easily recovered from such sources, and it is likely
that sewage and a wastewater harbor diverse phage populations
useful for a range of applications.
The majority of phages characterized in this study produced
plaques with halos, as described previously for phages shown
to be effective in controlling P. mirabilis crystalline biofilm
formation (Nzakizwanayo et al., 2016). The most common
explanation for plaques with halos is the presence of PD
activity in phages. The expression of PD enzymes is believed to
facilitate phage infection of host cells through degradation of
exterior capsules, or by providing access to biofilm associated
cells through the disruption of the encasing exopolymeric
matrix (Sutherland et al., 2004; Lu and Collins, 2007). This
feature appeared to be most apparent among the members of
the Podoviridae family characterized in this study (RS1pmA,
RS1pmB, RS3pmA, and RS8pmA), and these observations were
congruent with characteristics of P. mirabilis phages PM16 and
PM75 to which podophage examined in this study showed
notable similarity in terms of gene content (Morozova et al.,
2016, 2018). The potential importance of PD activity in the
control of biofilm formation has perhaps been most clearly
demonstrated by Lu and Collins, via the engineering of phage
T7 (Lu and Collins, 2007). In this study, T7 phages augmented
to express PD activity were significantly enhanced in their
ability to disperse established biofilms as compared to wild-type
counterparts (Lu and Collins, 2007).
However, no ORFs encoded by phages characterized in this
study were identified as encoding potential PD activity (based
on BlastP and Conserved Domain analyses); but it is possible
that these phages encode novel PD enzymes not currently well
represented in sequence databases. Alternatively, halos generated
by these phages may be the result of other processes, such as lysis
inhibition, where superinfection of cells leads to delays in cell
lysis and a zone of partially lysed cells around plaques that can
also manifest as a translucent halo (Hershey, 1946). Nevertheless,
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the putative PD activity of these phages, and confirmation of the
presence or absence of this activity, is likely to be important in
further studies of their potential to disrupt P. mirabilis biofilms.
PD activity may also have more direct pharmaceutical potential
in its own right, in terms of developing novel anti-biofilm agents.
Other features of these phage genomes may also hold similar
pharmaceutical potential in the context of developing novel
antimicrobial agents, such as ORFs predicted to be involved in
host cell lysis (Endersen et al., 2015; Czaplewski et al., 2016).
Of particular interest are the putative endolysins encoded by
RS1pmA and RS8pmA, which are involved in degradation of the
host cell wall to facilitate phage release during the final stages
of lytic replication. Although these enzymes have been found to
be highly effective against Gram-positive bacteria when applied
as exogenous preparations, the use of endolysins to control
Gram-negative bacteria has been hampered by the presence of
the outer lipopolysaccharide (LPS) membrane in these species,
which prevents access to the peptidoglycan layer and blocks the
anti-microbial action of these enzymes (Zimmer et al., 2002;
Donovan et al., 2006; Doehn et al., 2013; Briers et al., 2014;
Briers and Lavigne, 2015; Oliveira et al., 2016). The identification
and characterization of putative endolysins from phages infecting
Gram-negative bacteria may provide important insights and
biological raw materials to address this challenge. There is
already precedence for the identification of exogenously active
Gram-negative endolysins from phages infecting Acinetobacter
baumanii, and their potential use as alternatives to antibiotics
(Lai et al., 2011; Lood et al., 2015; Oliveira et al., 2016),
as well as for the engineering of these enzymes to improve
spectrum of activity (Briers et al., 2014; Yang et al., 2014;
Briers and Lavigne, 2015).
The genetic analysis of phages characterized here also
provided further insight into their performance in previous
evaluations of phage-mediated control of catheter blockage
(Nzakizwanayo et al., 2016), and their suitability with regard
to further development of phage therapy applications. We
previously demonstrated that a cocktail of RS1pmA, RS1pmB,
and RS3pmA could provide a significant increase in time
taken for catheters to block during simulations of established
CAUTI (Nzakizwanayo et al., 2016). When applied to models
simulating early colonization of the catheterized urinary tract,
these phages were able to eradicate infection and completely
prevent catheter blockage, whereas under conditions simulating
established infection they were only able to delay blockage
(Nzakizwanayo et al., 2016).
Characterization of the corresponding phage genomes in
this study now demonstrates these phages vary only by point
mutations in their genomes. This supports the hypothesis that
the eventual therapeutic failure during simulations of established
infection may have been due to development of resistance
(Nzakizwanayo et al., 2016), made possible by a lack of diversity
in the cocktail used. This further highlights the utility of phage
genome characterization in developing cocktails containing
diverse and distinct phage types, to offset development of
resistance in phage therapy applications. It should also be noted
that the activity of phages we characterized here have been
evaluated against only a small number of P. mirabilis isolates to
date. Recent serotyping studies indicated a high diversity among
UTI isolates with no predominant serotype (Kaca et al., 2011).
Analysis of phage activity against a broader panel of well-defined
P. mirabilis strains will also be important to the development
of phage therapies, and P. mirabilis strain diversity may present
additional challenges in this regard.
The characterization of phage genome sequences conducted
here also highlighted how more expansive characterization can
illuminate important facets of phage-host relations, and broader
ecological affiliations that may be relevant to development
of diverse, and effective combinations for phage therapy.
Comparison of ORFs encoded by these phages, with ORFs in
other phage genomes, showed most phages (RS1pmA, RS1pmB,
RS3pmA, and RS8pmA) had a strong association with other
available P. mirabilis phage genomes. This further highlighted the
potential novelty of RS51pmB, in which most ORFS were not
similar to those in any other phage genomes evaluated, and a clear
divergence from other P. mirabilis phages was evident.
To further illuminate broader phage-host relationships
relevant to the development of phage therapies, tetranucleotide
usage profiling was employed, which highlighted the potential
for extending host range to other problematic species involved in
CAUTI. The hypothesis underlying the tetranucleotide approach
is that co-evolution of host and phage leads to the development
of tetranucleotide usage profiles in phage genomes that are
similar to those found in the chromosomes of long-term bacterial
hosts (Pride et al., 2006; Ogilvie et al., 2012, 2013). As such,
phages that have more recently adapted to infect a particular
host should theoretically exhibit less conformity in this genome-
signature, and may exhibit tetranucleotide usage profiles more
aligned to previous or alternative host species, providing insight
into host-phage evolutionary relationships (Pride et al., 2006;
Ogilvie et al., 2012, 2013).
This analysis revealed that RS51pmB was much less closely
related to P. mirabilis than the other phages analyzed, and
instead was most closely associated with a range of other
members of the Morganellaceae family. The genome signature-
based prediction was subsequently supported by host range
assays which demonstrated the capacity for RS51pmB to infect
and replicate within M. morganii, albeit relatively inefficiently
compared with replication in P. mirabilis and only when
used at high titres. Taken together, these data indicated that,
in evolutionary terms, RS51pmB may have relatively recently
adapted to infect and replicate within P. mirabilis, and the
tetranucleotide genome signature of this phage has not yet
acclimated to the P. mirabilis host.
Although a potential transition of this phage from P. mirabilis
to M. morganii cannot be fully excluded, the clustering of
RS51pmB with M. morganii based on the tetranucleotide genome
signature, and the apparent ability to more readily replicate
in P. mirabilis, is more compatible with a transition from
Morganella to Proteus. This also raises the possibility of utilizing
such phage as the basis to more directly develop derivatives with
an extended spectrum of activity, for example using passage-
based methods such as the Appelmans technique (Appelmans,
1921) and a wider range of M. morganii clinical isolates.
This approach has already been utilized in the host range
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extension of P. mirabilis phages for development of broad-
spectrum cocktails (Lehman and Donlan, 2015). Nevertheless,
it should also be noted that while tetranucleotide profiling has
provided evidence that RS51pmB has a past relationship with
M. morganii, the host-range assays undertaken in this study
remain limited in scope overall. More expansive studies with
a greater range of bacterial strains should now be undertaken
to further evaluate the host-phage associations we observe
based on genome-signatures, and test the robustness of the
inferred evolutionary relationships. In particular, it will be
important to understand how consistent and reliable such
inferences are across different phage-host groups, datasets, and
taxonomic scales.
Characterization of phage diversity, and the ecological
success of different phages or phage encoded genes through
ecogenomic profiling, also has the potential to provide insights
into phages that are useful in biotechnological applications
(Ogilvie et al., 2012, 2013, 2018). This information may
help guide the selection of phages for inclusion in cocktails,
or those with properties useful in other biotechnological
applications, by facilitating identification of ecologically diverse
phages and those that have particular associations with
given habitats (Ogilvie et al., 2012, 2013, 2018). Notably, in
the ecogenomic analyses conducted here, there was a lack
of affiliation of any phage characterized with the human
urinary viromes analyzed, despite the dominance of phage
associated sequences in these datasets, and the diagnosis
of UTI in 50% of the individuals from which they were
derived (Santiago-Rodriguez et al., 2015). While this may
initially seem contradictory, it is unlikely that P. mirabilis
would constitute a member of the normal human urinary
microbiome, and none of the culture-positive samples from
which viromes were derived were found to contain P. mirabilis
(Santiago-Rodriguez et al., 2015).
Conversely, ecogenomic profiling reinforced the novelty of
RS51pmB observed in comparisons with other phage genomes,
but also provided a greater understanding of the broader
ecological associations of these phages. A distinct affiliation
with the human alimentary microbiome (oral and gut) was
observed for RS51pmB, and to a lesser extent RS1pmA and
RS8pmA, in keeping with P. mirabilis being a common member
of the human gut microbiome and the isolation of these
phages from sewage. The human gut-associated ecogenomic
profiles of RS51pmB may also highlight the possible value of
this phage in other biotechnological applications, such as in
the development of virome-based microbial source tracking
tools for monitoring water quality (Adriaenssens and Brister,
2017; Ogilvie et al., 2018). The gene-by-gene nature of this
analysis may also be relevant to bioprospecting studies seeking
to exploit specific attributes or functions encoded by phages,
where representation or activity within a particular habit may
be desirable. In this context, the recovery of these phage
from sewage reinforces the potential for wastewater treatment
facilities to also provide access to a wealth of biological
raw materials encoded by phages. However, it should also
be noted that ecogenomic studies are currently restricted by
the available metagenomic datasets, which represent only a
relatively small sample size for many habitats, and leave many
microbial ecosystems unrepresented (Ogilvie et al., 2012, 2013,
2018). Further research will be required to fully understand
how phage ecological profiles may best be used to inform
the development of phage therapy or exploit phage for
other applications.
Overall, the genetic characterization of phages considered in
this study, including evaluation of wider host-phage, ecological,
and evolutionary relationships, highlight the potential for these
broader genomic and ecogenomic assessments to assist in
identifying phage with the most potential for pharmaceutical
or biotechnological exploitation, or suitability for use in phage
therapy. It is also clear that a range of easily accessible “waste”
materials, such as sewage and wastewater, constitute useful
sources of novel and biotechnologically relevant phages. Given
the current rise in antimicrobial resistance and urgent need to
address this global challenge, it seems likely that alternatives
or supplements to conventional small molecule antimicrobials
will become an important feature of strategies to address this
problem (Zimmer et al., 2002). Phages are well suited to form
an important part of this solution, particularly with regard to
biofilm-associated infections, and approaches to help identify the
most promising phages for pharmaceutical or biotechnological
exploitation will be vital to the realization of more effective
phage-based products.
Currently, the selection of phages to be used for the
development of therapeutic applications is understandably
driven by phenotypic characterization and activity against target
pathogens, with genetic characterization often a secondary
activity primarily used to screen for undesirable genes such as
toxins. However, the generation of phage genome sequences is
now accessible and affordable, and the increasing range of tools
available for analyzing these data mean this aspect of phage
characterization should now be viewed as a primary process in the
selection of candidate phage for the development of therapeutic
products, or other biotechnological applications. Although next
generation sequencing technologies generating short reads (such
as Illumina platform sequencing) can pose challenges in the
correct assembly of some phage genomes, such approaches can
still provide useful information regarding phage gene content
and broader evolutionary relationships. However, technologies
such as single molecule nanopore sequencing can potentially
generate genome length reads, and we demonstrate here some of
their potential to address many of the current limitations of next
generation sequencing for phage genome analysis, related to read
length. Furthermore, platforms such as the Oxford Nanopore
MinION require no specialist genomics facilities or support to
operate, offering the possibility for genome characterization of
newly isolated phages to become a much more routine aspect of
phage characterization.
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